Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
GlobeNewswire (May 6, 2013)
-
-
GlobeNewswire (May 2, 2013)
-
-
-
-
-
-
-
GlobeNewswire (Apr 8, 2013)
-
-
-
-
-
-
GlobeNewswire (Mar 7, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
Earnings Preview: Celldex Therapeutics Reports August 10Vytautas Drumelis • Tue, Aug 7, 2012 -
-
-
-
-
Celldex's Vaccine Gets a BoostOhad Hammer • Mon, Aug 8, 2011 -
-
-
-
CellDex Therapeutics Is Back on the RadarVFC's Stock House • Wed, Oct 6, 2010
-
-
-
GlobeNewswire (May 6, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 8, 2013)
-
GlobeNewswire (Mar 7, 2013)
-
GlobeNewswire (Feb 11, 2013)
-
GlobeNewswire (Feb 8, 2013)
-
GlobeNewswire (Feb 5, 2013)
-
GlobeNewswire (Feb 4, 2013)
-
Business Wire (Dec 11, 2012)
-
Business Wire (Dec 7, 2012)
-
Business Wire (Dec 4, 2012)
-
at CNBC.com (Nov 30, 2012)
-
Business Wire (Nov 30, 2012)
-
at CNBC.com (Nov 28, 2012)
-
Business Wire (Nov 15, 2012)
-
Celldex Therapeutics Announces Upcoming Presentation at Lazard Capital Markets Healthcare ConferenceBusiness Wire (Nov 9, 2012)
CLDX vs. ETF Alternatives
Company Description
Celldex is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of... More
